Free Trial
→ There is a little known company that is changing warfare (From Reticulate) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 14 of 15

Slide 14
Back to 13
Continue to 15
 
Back to 13
Continue to 15
 

Avidity Biosciences (NASDAQ:RNA)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$63.22 (49.9% Upside)

About Avidity Biosciences

Avidity Biosciences logoAvidity Biosciences, Inc, a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/13/2024Chardan CapitalReiterated RatingBuy ➝ Buy$65.00 ➝ $65.00
11/13/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
10/31/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
10/30/2024Chardan CapitalBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.00
10/21/2024TD CowenBoost Price TargetBuy ➝ Buy$56.00 ➝ $78.00
9/24/2024The Goldman Sachs GroupInitiated CoverageBuy$59.00
9/16/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$96.00 ➝ $96.00
9/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$96.00 ➝ $96.00
8/28/2024BarclaysInitiated CoverageOverweight$63.00
8/26/2024Evercore ISILower Price TargetOutperform ➝ Outperform$54.00 ➝ $53.00
Slide 14
Back to 13
Continue to 15
 

There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

More From MarketBeat
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
7 Infrastructure Stocks to Buy Like There's No Tomorrow
Members of Congress agree on very few things. But in the last four years, there has been bipartisan support fo...
MarketBeat
Musk Says ‘Dollar Will Be Worth Nothing…’
Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...
Crypto 101 Media | Sponsored
7 Warren Buffett Stocks to Ride Out Market Volatility
Warren Buffett has been one of the most closely watched investors in the last half-century. The “Oracle ...
MarketBeat
Tech funds are hemorrhaging cash: Sell this stock now
Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...
Chaikin Analytics | Sponsored
The Top-Rated Dividend Stocks for 2023
MarketBeat tracks approximately 250,000 analyst recommendations each year and tracks more than 15,000 securiti...
MarketBeat